Cargando…
Eukaryotic translation initiation factor 5A in the pathogenesis of cancers
Cancer is the leading cause of death worldwide. The absence of obvious symptoms and insufficiently sensitive biomarkers in early stages of carcinoma limits early diagnosis. Cancer therapy agents and targeted therapy have been used extensively against tissues or organs of specific cancers. However, t...
Autores principales: | Ning, Liang, Wang, Lei, Zhang, Honglai, Jiao, Xuelong, Chen, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436936/ https://www.ncbi.nlm.nih.gov/pubmed/32863914 http://dx.doi.org/10.3892/ol.2020.11942 |
Ejemplares similares
-
Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers
por: Huang, Jinghong, et al.
Publicado: (2023) -
Clinical significance of eukaryotic translation initiation factor 5A2 in papillary thyroid cancer
por: Zhang, Hongmei, et al.
Publicado: (2020) -
Eukaryotic translation initiation factors as promising targets in cancer therapy
por: Hao, Peiqi, et al.
Publicado: (2020) -
The role of eukaryotic translation initiation factor 6 in tumors
por: Zhu, Wei, et al.
Publicado: (2017) -
Impact of Eukaryotic Translation Initiation Factors on Breast Cancer: Still Much to Investigate
por: Chen, Qin, et al.
Publicado: (2020)